<VariationArchive VariationID="977729" VariationName="NM_000377.3(WAS):c.1157del (p.Pro386fs)" VariationType="Deletion" Accession="VCV000977729" Version="5" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-28" DateCreated="2020-09-14" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="965873" VariationID="977729">
      <GeneList>
        <Gene Symbol="WAS" FullName="WASP actin nucleation promoting factor" GeneID="7454" HGNC_ID="HGNC:12731" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp11.23</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="48676636" stop="48691427" display_start="48676636" display_stop="48691427" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="48542185" stop="48549817" display_start="48542185" display_stop="48549817" Strand="+" />
          </Location>
          <OMIM>300392</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000377.3(WAS):c.1157del (p.Pro386fs)</Name>
      <CanonicalSPDI>NC_000023.11:48688880:CCCCC:CCCC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xp11.23</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="48688881" stop="48688881" display_start="48688881" display_stop="48688881" variantLength="1" positionVCF="48688880" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="48547270" stop="48547270" display_start="48547270" display_stop="48547270" variantLength="1" positionVCF="48547269" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>P386fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_125t1" sequenceAccession="LRG_125t1">
            <Expression>LRG_125t1:c.1157del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_125" sequenceAccession="LRG_125">
            <Expression>LRG_125:g.10089del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.48547274del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.48547274del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.48688885del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.48688885del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007877.1" sequenceAccession="NG_007877" sequenceVersion="1" change="g.10089del">
            <Expression>NG_007877.1:g.10089del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000377.3" sequenceAccession="NM_000377" sequenceVersion="3" change="c.1157del" MANESelect="true">
            <Expression>NM_000377.3:c.1157del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000368.1" sequenceAccession="NP_000368" sequenceVersion="1" change="p.Pro386fs">
            <Expression>NP_000368.1:p.Pro386fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="886041379" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000377.3(WAS):c.1157del (p.Pro386fs) AND multiple conditions" Accession="RCV001385415" Version="4">
        <ClassifiedConditionList TraitSetID="11545">
          <ClassifiedCondition DB="MedGen" ID="C1839163">Thrombocytopenia 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0043194">Wiskott-Aldrich syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1845987">X-linked severe congenital neutropenia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-05-05" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000377.3(WAS):c.1157del (p.Pro386fs) AND Wiskott-Aldrich syndrome" Accession="RCV001255566" Version="1">
        <ClassifiedConditionList TraitSetID="3075">
          <ClassifiedCondition DB="MedGen" ID="C0043194">Wiskott-Aldrich syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-08-05" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-08-05" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2020-09-14" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15284122</ID>
        </Citation>
        <DescriptionHistory Dated="2021-05-10">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="11545" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5640" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">X-linked severe congenital neutropenia</ElementValue>
                <XRef ID="MONDO:0010294" DB="MONDO" />
                <XRef ID="718882006" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">XLN</ElementValue>
                <XRef Type="MIM" ID="300299" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">SCNX</ElementValue>
                <XRef Type="MIM" ID="300299" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The WAS-related disorders, which include Wiskott-Aldrich syndrome, X-linked thrombocytopenia (XLT), and X-linked congenital neutropenia (XLN), are a spectrum of disorders of hematopoietic cells, with predominant defects of platelets and lymphocytes caused by pathogenic variants in WAS. WAS-related disorders usually present in infancy. Affected males have thrombocytopenia with intermittent mucosal bleeding, bloody diarrhea, and intermittent or chronic petechiae and purpura; eczema; and recurrent bacterial and viral infections, particularly of the ear. At least 40% of those who survive the early complications develop one or more autoimmune conditions including hemolytic anemia, immune thrombocytopenic purpura, immune-mediated neutropenia, rheumatoid arthritis, vasculitis, and immune-mediated damage to the kidneys and liver. Individuals with a WAS-related disorder, particularly those who have been exposed to Epstein-Barr virus (EBV), are at increased risk of developing lymphomas, which often occur in unusual, extranodal locations including the brain, lung, or gastrointestinal tract. Males with XLT have thrombocytopenia with small platelets; other complications of Wiskott-Aldrich syndrome, including eczema and immune dysfunction, are usually mild or absent. Males with XLN have congenital neutropenia, myeloid dysplasia, and lymphoid cell abnormalities.</Attribute>
                <XRef ID="NBK1178" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">WAS-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3981" />
                <XRef ID="3981" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301357</ID>
                <ID Source="BookShelf">NBK1178</ID>
              </Citation>
              <XRef ID="86788" DB="Orphanet" />
              <XRef ID="C1845987" DB="MedGen" />
              <XRef ID="MONDO:0010294" DB="MONDO" />
              <XRef Type="MIM" ID="300299" DB="OMIM" />
            </Trait>
            <Trait ID="6046" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Thrombocytopenia 1</ElementValue>
                <XRef ID="MONDO:0010743" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">THROMBOCYTOPENIA, X-LINKED, 1</ElementValue>
                <XRef Type="MIM" ID="313900" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300392.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300392.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300392.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300392.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300392.0016" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thrombocytopenia, X-linked</ElementValue>
                <XRef ID="Thrombocytopenia%2C+x-linked/7084" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked thrombocytopenia with normal platelets</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">THC1</ElementValue>
                <XRef Type="MIM" ID="313900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">XLT</ElementValue>
                <XRef Type="MIM" ID="313900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">WAS/XLT</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">THC</ElementValue>
                <XRef Type="MIM" ID="313900" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">WAS-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5176" />
                <XRef ID="5176" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The WAS-related disorders, which include Wiskott-Aldrich syndrome, X-linked thrombocytopenia (XLT), and X-linked congenital neutropenia (XLN), are a spectrum of disorders of hematopoietic cells, with predominant defects of platelets and lymphocytes caused by pathogenic variants in WAS. WAS-related disorders usually present in infancy. Affected males have thrombocytopenia with intermittent mucosal bleeding, bloody diarrhea, and intermittent or chronic petechiae and purpura; eczema; and recurrent bacterial and viral infections, particularly of the ear. At least 40% of those who survive the early complications develop one or more autoimmune conditions including hemolytic anemia, immune thrombocytopenic purpura, immune-mediated neutropenia, rheumatoid arthritis, vasculitis, and immune-mediated damage to the kidneys and liver. Individuals with a WAS-related disorder, particularly those who have been exposed to Epstein-Barr virus (EBV), are at increased risk of developing lymphomas, which often occur in unusual, extranodal locations including the brain, lung, or gastrointestinal tract. Males with XLT have thrombocytopenia with small platelets; other complications of Wiskott-Aldrich syndrome, including eczema and immune dysfunction, are usually mild or absent. Males with XLN have congenital neutropenia, myeloid dysplasia, and lymphoid cell abnormalities.</Attribute>
                <XRef ID="NBK1178" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301357</ID>
                <ID Source="BookShelf">NBK1178</ID>
              </Citation>
              <XRef ID="268322" DB="Orphanet" />
              <XRef ID="852" DB="Orphanet" />
              <XRef ID="C1839163" DB="MedGen" />
              <XRef ID="MONDO:0010743" DB="MONDO" />
              <XRef Type="MIM" ID="313900" DB="OMIM" />
            </Trait>
            <Trait ID="6264" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">WISKOTT-ALDRICH SYNDROME 1</ElementValue>
                <XRef Type="MIM" ID="301000" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Eczema thrombocytopenia immunodeficiency syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Immunodeficiency 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">IMD 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Aldrich syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Wiskott-Aldrich syndrome</ElementValue>
                <XRef ID="Wiskott+Aldrich+syndrome/7514" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010518" DB="MONDO" />
                <XRef ID="36070007" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Wiskott-aldrich syndrome, somatic</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">WAS1</ElementValue>
                <XRef Type="MIM" ID="301000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">IMD2</ElementValue>
                <XRef Type="MIM" ID="301000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">WAS</ElementValue>
                <XRef Type="MIM" ID="301000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">WAS-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7895" />
                <XRef ID="7895" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The WAS-related disorders, which include Wiskott-Aldrich syndrome, X-linked thrombocytopenia (XLT), and X-linked congenital neutropenia (XLN), are a spectrum of disorders of hematopoietic cells, with predominant defects of platelets and lymphocytes caused by pathogenic variants in WAS. WAS-related disorders usually present in infancy. Affected males have thrombocytopenia with intermittent mucosal bleeding, bloody diarrhea, and intermittent or chronic petechiae and purpura; eczema; and recurrent bacterial and viral infections, particularly of the ear. At least 40% of those who survive the early complications develop one or more autoimmune conditions including hemolytic anemia, immune thrombocytopenic purpura, immune-mediated neutropenia, rheumatoid arthritis, vasculitis, and immune-mediated damage to the kidneys and liver. Individuals with a WAS-related disorder, particularly those who have been exposed to Epstein-Barr virus (EBV), are at increased risk of developing lymphomas, which often occur in unusual, extranodal locations including the brain, lung, or gastrointestinal tract. Males with XLT have thrombocytopenia with small platelets; other complications of Wiskott-Aldrich syndrome, including eczema and immune dysfunction, are usually mild or absent. Males with XLN have congenital neutropenia, myeloid dysplasia, and lymphoid cell abnormalities.</Attribute>
                <XRef ID="NBK1178" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301357</ID>
                <ID Source="BookShelf">NBK1178</ID>
              </Citation>
              <XRef ID="906" DB="Orphanet" />
              <XRef ID="C0043194" DB="MedGen" />
              <XRef ID="MONDO:0010518" DB="MONDO" />
              <XRef Type="MIM" ID="301000" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3075" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6264" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">WISKOTT-ALDRICH SYNDROME 1</ElementValue>
                <XRef Type="MIM" ID="301000" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Eczema thrombocytopenia immunodeficiency syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Immunodeficiency 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">IMD 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Aldrich syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Wiskott-Aldrich syndrome</ElementValue>
                <XRef ID="Wiskott+Aldrich+syndrome/7514" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010518" DB="MONDO" />
                <XRef ID="36070007" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Wiskott-aldrich syndrome, somatic</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">WAS1</ElementValue>
                <XRef Type="MIM" ID="301000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">IMD2</ElementValue>
                <XRef Type="MIM" ID="301000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">WAS</ElementValue>
                <XRef Type="MIM" ID="301000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">WAS-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7895" />
                <XRef ID="7895" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The WAS-related disorders, which include Wiskott-Aldrich syndrome, X-linked thrombocytopenia (XLT), and X-linked congenital neutropenia (XLN), are a spectrum of disorders of hematopoietic cells, with predominant defects of platelets and lymphocytes caused by pathogenic variants in WAS. WAS-related disorders usually present in infancy. Affected males have thrombocytopenia with intermittent mucosal bleeding, bloody diarrhea, and intermittent or chronic petechiae and purpura; eczema; and recurrent bacterial and viral infections, particularly of the ear. At least 40% of those who survive the early complications develop one or more autoimmune conditions including hemolytic anemia, immune thrombocytopenic purpura, immune-mediated neutropenia, rheumatoid arthritis, vasculitis, and immune-mediated damage to the kidneys and liver. Individuals with a WAS-related disorder, particularly those who have been exposed to Epstein-Barr virus (EBV), are at increased risk of developing lymphomas, which often occur in unusual, extranodal locations including the brain, lung, or gastrointestinal tract. Males with XLT have thrombocytopenia with small platelets; other complications of Wiskott-Aldrich syndrome, including eczema and immune dysfunction, are usually mild or absent. Males with XLN have congenital neutropenia, myeloid dysplasia, and lymphoid cell abnormalities.</Attribute>
                <XRef ID="NBK1178" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301357</ID>
                <ID Source="BookShelf">NBK1178</ID>
              </Citation>
              <XRef ID="906" DB="Orphanet" />
              <XRef ID="C0043194" DB="MedGen" />
              <XRef ID="MONDO:0010518" DB="MONDO" />
              <XRef Type="MIM" ID="301000" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2827775" SubmissionDate="2020-09-09" DateLastUpdated="2020-09-14" DateCreated="2020-09-14">
        <ClinVarSubmissionID localKey="NM_000377.2:c.1157delC|MedGen:C0043194" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001432047" DateUpdated="2020-09-14" DateCreated="2020-09-14" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-08-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>Variant summary: WAS c.1157delC (p.Pro386LeufsX59) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant was absent in 106816 control chromosomes (gnomAD). To our knowledge, no occurrence of c.1157delC in individuals affected with Wiskott-Aldrich Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="WAS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000377.2:c.1157delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Wiskott-Aldrich syndrome</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0043194" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8118025</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3110897" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="10560514|MedGen:C0043194;C1845987;C1839163" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001585251" DateUpdated="2024-02-28" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-05-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15284122</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in WAS are known to be pathogenic (PMID: 15284122). This variant has not been reported in the literature in individuals with WAS-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate insufficient coverage at this position in the ExAC database. This sequence change creates a premature translational stop signal (p.Pro386Leufs*59) in the WAS gene. It is expected to result in an absent or disrupted protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="WAS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.48547270del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0043194" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1845987" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1839163" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3110897" TraitType="Disease" MappingType="XRef" MappingValue="C0043194" MappingRef="MedGen">
        <MedGen CUI="C0043194" Name="Wiskott-Aldrich syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3110897" TraitType="Disease" MappingType="XRef" MappingValue="C1845987" MappingRef="MedGen">
        <MedGen CUI="C1845987" Name="X-linked severe congenital neutropenia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3110897" TraitType="Disease" MappingType="XRef" MappingValue="C1839163" MappingRef="MedGen">
        <MedGen CUI="C1839163" Name="Thrombocytopenia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2827775" TraitType="Disease" MappingType="Name" MappingValue="Wiskott-Aldrich syndrome" MappingRef="Preferred">
        <MedGen CUI="C0043194" Name="Wiskott-Aldrich syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

